This company has been acquired
このページの翻訳は実験的なもので、現在開発中です。お待ちしております!
Pardes Biosciences 配当金
配当金 基準チェック /06
Pardes Biosciences does not have a record of paying a dividend.
主要情報
n/a
配当利回り
n/a
配当性向
業界平均利回り | 2.8% |
次回配当支払日 | n/a |
配当落ち日 | n/a |
一株当たり配当金 | n/a |
一株当たり利益 | -US$1.25 |
3年後の配当利回り予想 | n/a |
最近の配当金アップデート
更新なし
Recent updates
We're Keeping An Eye On Pardes Biosciences' (NASDAQ:PRDS) Cash Burn Rate
Jul 18Here's Why We're Watching Pardes Biosciences' (NASDAQ:PRDS) Cash Burn Situation
Jan 20We Think Pardes Biosciences (NASDAQ:PRDS) Needs To Drive Business Growth Carefully
Oct 01Pardes begins phase 2 trial of oral drug PBI-0451 for COVID-19
Sep 13Pardes Biosciences GAAP EPS of -$0.48
Aug 15Pardes Biosciences (NASDAQ:PRDS) Is In A Good Position To Deliver On Growth Plans
Jun 14Pardes Biosciences: Advancing A Viral Protease Inhibitor Platform
Jan 21決済の安定と成長
配当データの取得
安定した配当: Insufficient data to determine if PRDS's dividends per share have been stable in the past.
増加する配当: Insufficient data to determine if PRDS's dividend payments have been increasing.
配当利回り対市場
Pardes Biosciences 配当利回り対市場 |
---|
セグメント | 配当利回り |
---|---|
会社 (PRDS) | n/a |
市場下位25% (US) | 1.5% |
市場トップ25% (US) | 4.7% |
業界平均 (Biotechs) | 2.8% |
3年後のアナリスト予想 (PRDS) | n/a |
注目すべき配当: Unable to evaluate PRDS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
高配当: Unable to evaluate PRDS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
株主への利益配当
収益カバレッジ: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
株主配当金
キャッシュフローカバレッジ: Unable to calculate sustainability of dividends as PRDS has not reported any payouts.